Company Filing History:
Years Active: 2023-2024
Title: Innovations of Inventor Soo-Jin Lee
Introduction
Soo-Jin Lee is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative compounds. With a total of 2 patents to his name, his work focuses on advancing medical treatments through novel chemical compounds.
Latest Patents
Soo-Jin Lee's latest patents include groundbreaking research on autotaxin inhibitor compounds. The present disclosure provides autotaxin (ATX) inhibitor compounds and compositions that include these compounds. It also outlines methods for using these compounds and compositions to inhibit ATX, along with methods for preparing these compounds and their synthetic precursors. Another significant patent involves substituted pyrazolo[4,3-d]pyrimidines and imidazo[5,1-f][1,2,4]triazines as dual inhibitors of androgen receptors and phosphodiesterase 5 (PDE-5). This patent details compounds that can inhibit both AR and PDE-5, providing dual functionality in biological systems.
Career Highlights
Soo-Jin Lee is currently associated with Il Dong Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to enhancing therapeutic options for various medical conditions.
Collaborations
Some of his notable coworkers include Jeong-Ah Kim and Jun-Su Ban, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Soo-Jin Lee's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in advancing medical science. His work continues to pave the way for new treatments and therapies.